Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2014; 20(45): 17141-17147
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17141
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17141
Table 2 Mean survival periods and survival rates of different groups
| Groups | Mean survival periods (mo) | 1 yr survival rate | 2 yr survival rate | 3 yr survival rate |
| Conservative treatment | 3.8 | 0% | 0% | 0% |
| TACE | 7.0 | 17.5% | 0% | 0% |
| Hepatic resection | 8.2 | 28% | 20% | 15% |
| Hepatic resection with TACE | 15.1 | 49% | 37% | 19% |
- Citation: Ye JZ, Zhang YQ, Ye HH, Bai T, Ma L, Xiang BD, Li LQ. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol 2014; 20(45): 17141-17147
- URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17141.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i45.17141